Quest Diagnostics (NYSE:DGX) Rating Lowered to Hold at StockNews.com : vimarsana.com

StockNews.com cut shares of Quest Diagnostics (NYSE:DGX – Free Report) from a buy rating to a hold rating in a research report released on Friday morning. DGX has been the subject of a number of other research reports. Barclays lifted their price target on shares of Quest Diagnostics from $138.00 to $144.00 and gave the […]

Related Keywords

United States , Wellington , New Zealand General , New Zealand , American , Catherinet Doherty , Michaele Prevoznik , , Barclays , Citigroup , Wellington Management Group , Jpmorgan Chase Co , Victory Capital Management Inc , Invesco Ltd , Quest Diagnostics , American Century Companies Inc , Securities Exchange Commission , Quest Diagnostics Incorporated , Free Report , Diagnostics Stock Down , Get Free Report , Exchange Commission , Century Companies , Capital Management , Management Group , Diagnostics Incorporated , Quest Diagnostics Daily , Nyse Dgx , Dgx , Medical , 74834l10 , Downgrade , Stocknews Com ,